Epigenomic signatures of sarcomatoid differentiation to guide the treatment of renal cell carcinoma
Talal El Zarif(Yale University), Sylvan C. Baca(Broad Institute)
Cited by 26
Related Papers
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma
|Nature Communications|2021|167
Liquid biopsy epigenomic profiling for cancer subtyping
|Nature Medicine|2023|119
Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors
|Cancer Cell|2022|117
Germline variants associated with toxicity to immune checkpoint blockade
|Nature Medicine|2022|106
Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid Tumors
|Cancer Immunology Research|2020|79